Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD. (Q46848188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

title

Long-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

1

Joseph Biederman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

3

Timothy E Wilens

1 reference

10 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

author name string

Thomas J Spencer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

Richard H Weisler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

Stephanie C Read

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

Simon J Tulloch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

SLI381.304 study group

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

issue

12 Suppl 20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

16-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Attention-Deficit/Hyperactivity Disorder in Adults

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Is attention-deficit hyperactivity disorder in adults a valid disorder?

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Attention-deficit/hyperactivity disorder in adults: an overview

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Gender effects on attention-deficit/hyperactivity disorder in adults, revisited

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017/S1092852950002406

7 January 2021

10.1017/S1092852950002406

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16344837 AND SRC:MED&resulttype=core&format=json

10 January 2020

1 reference